[INQ. NO. 2605E04] MBLab is an innovative technology company that develops solutions to improve women’s quality of life through AI- and data-based digital healthcare technologies. Focusing on women’s pelvic health and wellness (Pelvic Wellness), the company combines medical expertise with user experience to expand its presence in the global Femtech market.
With the vision of understanding women through AI and data, and redefining health in life, MBLab aims to evolve into a personalized health management platform.
MBLab’s core mission is built on scientific, evidence-based technology development, user-centered health experience design, and global market expansion. By utilizing data and AI, the company develops personalized health solutions while incorporating the insights of medical professionals to deliver practical wellness experiences. At the same time, it is accelerating global expansion through overseas distribution and strategic partnerships.

In Korea, MBLab has already supplied its VVP3500 diagnostic device and RT4000 urinary incontinence treatment system to 250 hospitals, where they are actively used in clinical settings.

In Japan, MBLab has exported its AI- and data-based pelvic-health solution Ekegel, thereby establishing a foothold in the market. Through participation in MEDICA 2025 and CES 2026, the company has drawn interest from global buyers, and is advancing its international marketing efforts.
MBLab recently introduced locally not merely a conventional Kegel device, but an AI-based personalized Pelvic Wellness Platform. The solution is structured as an intelligent pelvic floor management system that integrates measurement, analysis, personalized exercise, and feedback. It analyzes contraction, endurance, and relaxation data, incorporates a 12-item vaginal health checklist, classifies users based on AI algorithms, and automatically sets optimal exercise intensity tailored to each individual.
The platform is positioned as a clinically recognized product used in hospitals and medical channels. By going beyond a simple exercise device and providing a data-driven continuous management system, it enhances the precision of women’s health management. It is applicable to various conditions, including urinary incontinence, postpartum recovery, and pelvic health management for middle-aged women.
MBLab aimed at increasing awareness of AI-based pelvic health solutions in the domestic healthcare market, discovering hospital, clinic, and distribution partners, and gathering feedback from medical professionals in order to further refine its products. At the same time, the company seeks to strengthen domestic references to support its global expansion strategy.
MBLab’s global strategy will proceed in three phases: first, establishing a foundation for entry into the North American market; second, expanding in Japan and securing entry opportunities in Europe; and third, targeting premium markets in the Middle East and China.
Following participation in MEDICA 2025 and CES 2026, MBLab plans to attend CES 2027 and healthcare exhibitions in Dubai, while continuing to expand its domestic and international network through participation in future KIMES events.
Through its AI-based personalized pelvic-health management platform, MBLab aims to present a new standard in women’s wellness and strengthen its competitiveness in the global Femtech market as a data-driven technology company.

 
 
korean-electronics.com | Blog Magazine of korean electronics, brands and Goods